PuSH - Publication Server of Helmholtz Zentrum München

Klonisch, T.* ; Glogowska, A.* ; Gratao, A.A.* ; Grzech, M.* ; Nistor, A.* ; Torchia, M.* ; Weber, E.* ; Hrabě de Angelis, M. ; Rathkolb, B. ; Hoang-Vu, C.* ; Wolf, E.* ; Schneider, M.R.*

The C-terminal cytoplasmic domain of human proEGF is a negative modulator of body and organ weights in transgenic mice.

FEBS Lett. 583, 1349-1357 (2009)
DOI
Open Access Green as soon as Postprint is submitted to ZB.
We generated transgenic mice to study the in vivo role of the cytoplasmic domain of human proEGF (proEGFcyt). Post-pubertal proEGFcyt transgenic (tg) mice displayed an up to 15% reduction in body weight, including smaller kidney and brain weights as compared to control littermates. Renal histology, gene expression profiles, and functional parameters were normal. In both sexes, serum levels of IGFBP-3 were reduced. Circulating IGF-I/IGF-II levels were unchanged. Histomorphological analysis revealed isolated foci of liver necrosis specific to proEGFcyt tg mice. In conclusion, we identified proEGF cytoplasmic domain as a novel modulator of whole body and organ-specific growth in mice.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords proEGF cytoplasmic domain; Kidney; Transgenic; Growth; IGFBP-3; epidermal-growth-factor; polarized epithelial-cells; thyroid-carcinoma cells; factor receptor ligands; canine kidney-cells; factor-alpha; hb-egf; binding-proteins; factor precursor; tgf-alpha
ISSN (print) / ISBN 0014-5793
e-ISSN 1873-3468
Journal FEBS Letters
Quellenangaben Volume: 583, Issue: 8, Pages: 1349-1357 Article Number: , Supplement: ,
Publisher Elsevier
Reviewing status Peer reviewed